logo

Roche Holding Ag (RHHBY)



Trade RHHBY now with
  Date
  Headline
7/14/2020 1:07:46 AM Blueprint Medicines Collaborates With Roche To Develop &Commercialize Pralsetinib For Patients With RET-Altered Cancers
7/14/2020 1:04:39 AM Roche, Blueprint Medicines Announce Signing Of Licensing And Collaboration Agreement
7/13/2020 7:04:35 AM Roche, Summit Cancer Centers To Patner On Use Of New Digital Healthcare Tools To Enable Cancer Care
7/13/2020 1:07:12 AM Genentech Announces Results From Second Interim Analysis Of Phase IIIb STASEY Study
7/13/2020 1:05:41 AM Genentech Says Phase III IMagyn050 Study Did Not Meet Primary Endpoint Of Progression-free Survival
7/12/2020 11:15:04 AM Spark Therapeutics Updates Data On SPK-8011 From Phase 1/2 Clinical Trial In Hemophilia A
7/2/2020 1:03:41 AM Ipsen Joins Clinical Collaboration With Exelixis And Roche To Evaluate Cabozantinib Plus Atezolizumab
6/29/2020 1:06:35 PM FDA Approves Genentech's Phesgo For HER2-positive Breast Cancer
6/29/2020 9:34:36 AM Roche To Present New Data From Its Haemophilia A Clinical Programme
6/29/2020 5:02:54 AM Roche Says ENSPRYNG Approved In Japan For Neuromyelitis Optica Spectrum Disorder
6/26/2020 1:51:29 AM Roche Announces CE-IVD Launch Of Automated Digital Pathology Algorithm, The UPath PD-L1 (SP263) Image Analysis
6/19/2020 10:22:20 AM Roche Gets FDA Approval For Cobas EZH2 Mutation Test As Companion Diagnostic For Patients With Follicular Lymphoma